About H1N1 vaccine, H1N1vaccine production, H1N1 vaccine manufacturers

Researchers from Mount Sinai School of Medicine have found high levels of food toxins called Advanced Glycation End products (AGEs) in infants. Excessive food AGEs, through both maternal blood transmission and baby formula, could together significantly increase children’s risk for diseases such as diabetes from a very young age. A second study of AGEs in adults found that cutting back on processed, grilled, and fried foods, which are high in AGEs, may improve insulin resistance in people with diabetes. AGEs — toxic glucose byproducts previously tied to high blood sugar — are found in most heated foods and, in fantastic excess, in commercial infant formulas. Read more…

Obesity among adolescents has more than tripled over the past 40 years, and recent estimates find that over 18% of teens in the U.S. are obese. Education and mentoring targeting obesity and delivered in high schools by peers has been shown to have a significant impact on teen diet and physical activity, according to a study published in Childhood Obesity, a peer-reviewed journal published by Mary Ann Liebert, Inc. Read more…

A Johns Hopkins Children’s Center study of young people with melanoma, a deadly form of skin cancer, has found that some children have a higher risk of invasive disease than adults. The study, published online Oct. 5 in the journal Cancer, is believed to be the first to compare disease spread in children and adults, and the results suggest some profound biological differences between childhood and adult melanoma, the researchers say. Read more…

North American babies who buy toxoplasmosis infections in the womb show much higher rates of brain and eye hurt than European infants with the same infection, according to new research from the Stanford University School of Medicine. Read more…

Indoor spraying with the insecticide bendiocarb has dramatically decreased malaria transmission in many parts of Benin, new evidence that insecticides remain a potent weapon for fighting malaria in Africa despite the rapid rise of resistance to an entire class of mosquito-killing compounds, according to a study published October 5 in the October edition of The American Journal of Tropical Medicine and Hygiene. Read more…

Investigators at the Stanford University School of Medicine have developed a novel protocol that allows kidney-transplant recipients to jettison their indispensable immune-suppressing drugs. The protocol could also spell substantial savings to the health-care system. Read more…

A study by researchers at the University of California, San Diego School of Medicine may lead to a way to prevent the progression, or induce the regression, of lung injury that results from use of the anti-cancer chemotherapy drug Bleomycin. Pulmonary fibrosis caused by this drug, as well as Idiopathic Pulmonary Fibrosis (IPF) from unknown causes, affect nearly five million people worldwide. No therapy is known to improve the health or survival of patients. Read more…

Treating women with early stage breast cancer with a combination of chemotherapy and the molecularly targeted drug Herceptin significantly increases survival in patients with a specific genetic mutation that results in very aggressive disease, a researcher with UCLA’s Jonsson Comprehensive Cancer Center reports. Read more…

A large study of the daughters of women who had been given DES, the first synthetic form of estrogen, during pregnancy has found that exposure to the drug while in the womb (in utero) is associated with many reproductive problems and an increased risk of certain cancers and pre-cancerous conditions. Read more…

A possible new target for breast cancer therapy comes from the discovery that the Tyk2 protein helps suppress the growth and metastasis of breast tumors, as reported in Journal of Interferon & Cytokine Research, a peer-reviewed journal published by Mary Ann Liebert, Inc. Read more…